About Peter Moldt
Form D filings for Avalyn Pharma in 2023 list Peter Moldt as director.
Peter Moldt first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Peter Moldt in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Peter Moldt works with at each company, as listed on that company's latest Form D.
Avalyn Pharma Inc. · Form D, Oct 10, 2023
LB
Lyn Baranowski
Chief Executive Officer and director
TA
Tiba Aynechi
Director
KP
Ketan Patel
Director
ND
Niall O'Donnell
Director
CL
Cassandra Luca
Director
JL
Jonathan Leff
Director
JC
Jill Carroll
Director